BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35048405)

  • 1. MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways.
    Ponnusamy L; Natarajan SR; Manoharan R
    J Cell Biochem; 2022 Apr; 123(4):759-771. PubMed ID: 35048405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway.
    Natarajan SR; Ponnusamy L; Manoharan R
    Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119242. PubMed ID: 35192892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways.
    Ponnusamy L; Manoharan R
    Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118975. PubMed ID: 33545220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
    Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X
    Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
    Sudhagar S; Sathya S; Lakshmi BS
    Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic Glycolysis Induced by mTOR/HIF-1α Promotes Early Brain Injury After Subarachnoid Hemorrhage via Activating M1 Microglia.
    Sun XG; Chu XH; Godje Godje IS; Liu SY; Hu HY; Zhang YB; Zhu LJ; Wang H; Sui C; Huang J; Shen YJ
    Transl Stroke Res; 2024 Feb; 15(1):1-15. PubMed ID: 36385451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withaferin A Inhibits Liver Cancer Tumorigenesis by Suppressing Aerobic Glycolysis through the p53/IDH1/HIF-1α Signaling Axis.
    Zhou X; Wu D; Zhu L; Li R; Yu H; Li W
    Curr Cancer Drug Targets; 2024; 24(5):534-545. PubMed ID: 38804345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
    Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
    J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00365 functions as a tumor suppressor by inhibiting HIF-1α-mediated glucose metabolism reprogramming in breast cancer.
    Liu B; Qu X; Wang J; Xu L; Zhang L; Xu B; Su J; Bian X
    Exp Cell Res; 2023 Apr; 425(1):113514. PubMed ID: 36804531
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
    Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
    [No Abstract]   [Full Text] [Related]  

  • 14. Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
    Li G; Shan C; Liu L; Zhou T; Zhou J; Hu X; Chen Y; Cui H; Gao N
    PLoS One; 2015; 10(2):e0117440. PubMed ID: 25659153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
    Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
    Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
    Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M
    Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB.
    Rohwer N; Dame C; Haugstetter A; Wiedenmann B; Detjen K; Schmitt CA; Cramer T
    PLoS One; 2010 Aug; 5(8):e12038. PubMed ID: 20706634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
    Shi L; He C; Li Z; Wang Z; Zhang Q
    Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.
    Cheng SC; Quintin J; Cramer RA; Shepardson KM; Saeed S; Kumar V; Giamarellos-Bourboulis EJ; Martens JH; Rao NA; Aghajanirefah A; Manjeri GR; Li Y; Ifrim DC; Arts RJ; van der Veer BM; Deen PM; Logie C; O'Neill LA; Willems P; van de Veerdonk FL; van der Meer JW; Ng A; Joosten LA; Wijmenga C; Stunnenberg HG; Xavier RJ; Netea MG
    Science; 2014 Sep; 345(6204):1250684. PubMed ID: 25258083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.